Literature DB >> 15096716

[Genotypes of hepatitis B virus on Jeju island].

Ji-Hyun Cho1, Do-Shim Park, Tae-Hyeon Kim, Joo-Jin Yeom, Haak-Cheoul Kim, Ju-Heun Moon, Jae-Sik Yang.   

Abstract

BACKGROUND/AIMS: Hepatitis B virus (HBV) was classified into 8 genotypes by a sequence divergence in the entire genome designated from A to H. HBV genotypes have distinct geographic distributions. Recently, HBV genotypes have been partially found as influencing the clinical manifestation of chronic liver disease in hosts. In Korea, the distribution of HBV genotypes remains unclear. The aim of this study was to evaluate the prevalence of the HBV genotype on Jeju Island.
METHODS: Hepatitis B virus genotypes were evaluated among 107 hepatitis B carriers residing on Jeju Island. We used single PCR and multiplex-PCR assay with genotype-specific primer pairs for HBV genotypes A-F for the genotyping.
RESULTS: 1. Fifty nine samples (55%) were positive for HBV DNA. The positivity was different according to the pattern of HBeAg/ anti-HBe expression, as -/-; 2/3 (66.7%), -/+; 30/73 (30%), +/-; 24/28 (85.7%) and +/+; 3/3 (100%). 2. In the single primer set of genotype-specific PCR, 59 samples (100%) were detected as genotype C and 2 (3%) were also detected as genotype A and B. 3. In multiplex-PCR, 58 samples (98%) were detected as genotype C and only one (2%) as a mixed pattern of genotype B and C. 4. When the PCR products were amplified with universal sense and genotype specific anti-sense from one genotype A, one B, and 2 C, all were included in genotype C.
CONCLUSIONS: These results suggest that on Jeju Island, almost all HBV genotypes are C.

Entities:  

Mesh:

Year:  2004        PMID: 15096716

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  2 in total

1.  Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

Authors:  Si Hyun Bae; Seung Kew Yoon; Jeong Won Jang; Chang Wook Kim; Soon Woo Nam; Jong Young Choi; Boo Sung Kim; Young Min Park; Seiji Suzuki; Fuminaka Sugauchi; Masashi Mizokami
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

2.  Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study.

Authors:  Young Chang; Sang-Gyune Kim; Soung-Won Jeong; Jae-Young Jang; Jeong-Ju Yoo; Sae-Hwan Lee; Young-Seok Kim; Hong-Soo Kim; Hyun-Woong Lee; Suyeon Park
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.